Protagen’s Cancer Immunotherapy Array will be used to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors
ERS Genomics Limited and DefiniGEN Ltd announced a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents
Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology